Phentolamine- and clonidine-induced changes in plasma neuropeptide Y-like immunoreactivity during sympathetic activation in man.

[1]  P. Hjemdahl,et al.  Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man. , 2008, Clinical physiology.

[2]  J. Lundberg,et al.  Alpha 2-adrenoceptor-mediated inhibition of nerve stimulation-evoked release of neuropeptide Y (NPY)-like immunoreactivity in the pithed guinea-pig. , 1986, European journal of pharmacology.

[3]  J. Lundberg,et al.  Radioimmunoassay for neuropeptide Y (NPY): chromatographic characterization of immunoreactivity in plasma and tissue extracts. , 1985, Scandinavian journal of clinical and laboratory investigation.

[4]  J. Pernow,et al.  Guanethidine-sensitive release of neuropeptide Y-like immunoreactivity in the cat spleen by sympathetic nerve stimulation , 1984, Neuroscience Letters.

[5]  J. Atterhög,et al.  Effects of Prazosin on Hemodynamics and Sympatho‐Adrenal Activity in Hypertensive Patients , 1983, Journal of cardiovascular pharmacology.

[6]  T. Hökfelt,et al.  Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. , 1982, Acta physiologica Scandinavica.

[7]  J. Lundberg,et al.  Pancreatic polypeptide family (APP, BPP, NPY and PYY) in relation to sympathetic vasoconstriction resistant to alpha-adrenoceptor blockade. , 1982, Acta physiologica Scandinavica.

[8]  S. Z. Langer,et al.  Recent Developments In Noradrenergic Neurotransmission and its Relevance to the Mechanism of Action of Certain Antihypertensive Agents , 1980, Hypertension.